Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Similar documents
European status report on alcohol and health Leadership, awareness and commitment

Alcohol-related harm in Europe and the WHO policy response

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Q1 What age are you?

European Status report on Alcohol and Health

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

The cancer burden in the European Union and the European Region: the current situation and a way forward

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Highlighting in the WHO European Region:

Cause for Alarm: The Incarceration of Women for Drug Offences in Europe and Central Asia, and the need for Legislative and Sentencing Reform

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Smokefree Policies in Europe: Are we there yet?

Where we stand in EFORT

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

LEBANON. WCPT COUNTRY PROFILE December 2018

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

DENMARK. WCPT COUNTRY PROFILE December 2018

Engagement in language assessment / Regions of Europe

GERMANY. WCPT COUNTRY PROFILE December 2018

EUDY CHILDREN CAMP 2017 FIRST ANNONUCEMENT

Noncommunicable diseases progress monitoring. Are we meeting the time-bound United Nations targets?

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Cannabis policies & cannabis use

European Collaboration on Dementia. Luxembourg, 13 December 2006

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Development of Palliative Care services in different countries

Overall survival: 1 st line therapy

Real Life, Real PD Survey

Inequality in injury risks

Summary. Primary care data. Week 49/2014. Season

Overview of drug-induced deaths in Europe - What does the data tell us?

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Cross Border Genetic Testing for Rare Diseases

Prevention of Oral Cancer Special Interest Working Group

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

European Association of Dental Public Health Prevention of Oral Cancer

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

11 Melanoma of the skin

Long Term Forensic Psychiatric Care in the Netherlands. Peter Braun Pompestichting Nijmegen/Zeeland/Vught. 8th of November 2018

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Table 6.1 Summary information for colorectal cancer in Ireland,

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

SVERIGES DÖVAS UNGDOMSFÖRBUND (SDUF), SWEDISH YNAD

Table 7.1 Summary information for lung cancer in Ireland,

Table 9.1 Summary information for stomach cancer in Ireland,

General Discussion on "Access to Justice" 18 February 2013

Monitoring noncommunicable disease commitments in Europe Theme in focus: progress monitor indicators

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Cardiovascular disease in Europe: epidemiological update 2016

CND UNGASS FOLLOW UP

Access to treatment and disease burden

Better Health for All in Latvia

Drug laws, penalties and alternatives across Europe

Positioning health equity and the social determinants of health on the regional development agenda Investment for health and development in Slovenia

Percutaneous Mitral Valve Therapies

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Acknowledgements. Wild birds and the risk of a pandemic. Overview of the presentation

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Vaccinations pre- and posttransplant. Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Budapest, Hungary, September 2017 xx July xxx. Progress reports

E/INCB/2009/1 D. Europe 1. Major developments 106

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

MEDICINES SHORTAGES PGEU GPUE. John Chave - Secretary general. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

PLACEMENT AND TREATMENT OF MENTALLY ILL OFFENDERS LEGISLATION AND PRACTICE IN EU-MEMBER STATES

This document is a preview generated by EVS

European Community Pharmacy: a reference in Public Health

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Underage drinking in Europe

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Monthly measles and rubella monitoring report

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Best practices in collecting and processing data in CRC screening and after it

Transcription:

Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of female prisoners incarcerated for drug offences in some countries Russia incarcerates over twice as many women for drug offences as all EU countries combined Monday, 12 March 2012 (Vienna, Austria)-- Over 31,000 women across Europe and Central Asia are imprisoned for drug offences, representing 28 percent of all women in prisons in these regions, according to a new report by Harm Reduction International.(1) The report, Cause for Alarm: The Incarceration of Women for Drug Offences in Europe and Central Asia, and the need for Legislative and Sentencing Reform, the first to calculate the total number of females in prisons on drug offences in Europe and Central Asia, was launched on the opening day of the annual meeting of the UN Commission on Narcotic Drugs, which is taking place in Vienna March 12-16. The report collected data from fifty-one European and Central Asian countries between August 2011 and February 2012 through government agencies, 1

including national prison services, ministries of justice and drug agencies; as well as academic researchers and civil society organisations. Drug offences include possession, preparation, production, purchase and sale of illicit substances. In some countries (Latvia, Tajikistan) more than half of female prisoners, are imprisoned for non-violent drug offences. Moreover, in Russia, almost 20,000 women are imprisoned for drugs, more than double the number in 2005 and which exceeds double the amount of women in prison in the countries of the European Union combined. Women are disproportionately facing prison for non-violent drug offences, often as a result of poverty and social marginalisation, said Eka Iakobishvili, Human Rights Analyst at Harm Reduction International, and author of the report, who is attending the CND meeting. Many of these women have problems, including with drug and alcohol dependency, and are in need of support, not punishment. This research points to an over-reliance on criminal laws to address social and economic problems in many countries. The report also confirms that (2) (3): 1in 4 women in prisons across Europe and Central Asia are incarcerated for drugs, some 31,400 women of a total of 112,575 presently incarcerated in that region; Just over a third of the 51 countries studied have a higher proportion of women prisoners convicted of drug offences than the regional rate of 28%. In Spain, the number of females prisoners on drug offences between 2006 and 2010 increased some 50 per cent, from 1625 to 2326. In Spain almost 10 times as many women (2,935) are incarcerated for drug offences compared to France (308). In Portugal where decriminalisation of personal possession was introduced in 2001, 47.6 percent of female prisoners are incarcerated for drug offences. A recent UN Women report found that most offences for which women are imprisoned are crimes of poverty and are nonviolent, property or drug-related. Globally, women are imprisoned for drug offences more than for any other crime. (4) Harm Reduction International estimates there to be over 112,000 women in prisons across Europe and Central Asia, with over 31,000 imprisoned for drug offences, based on official data from prison services, and research conducted by local civil society organisations and academic scholars. According to Harm Reduction International, incarceration for drug offences is driving the increasing female prison population in the region, especially in Russia. Casting women into prison for non-violent drug offences routinely ruins lives, breaks families apart and puts children at serious risk, said HRI s Deputy Executive Director, Damon Barrett who is attending the CDN meeting. Numbers as high as Russia s represent a tremendous failure in public policy. It and other 2

governments need to shift their focus away from arrests, prosecutions, prison and, if at all possible, the criminal justice system and into sentencing reforms. Globally women represent a small proportion of all prisoners - between 2-10 per cent, depending on the country. Harm Reduction International s research suggests that this low proportion of all prisoners hides the role of drug enforcement in driving the imprisonment of women. In its report Harm Reduction International recommends the following: the decriminalization of personal possession to divert minor possession offences from the criminal justice system; presumptions against incarcerating mothers, with authorities acting always in the best interests of the child; national reviews of laws and regulations relating to thresholds and quantities; the establishment of clear guidelines on mitigating factors, including where exploitation is evident. Notes to editors: (1) Cause for Alarm: The Incarceration of Women for Drug Offences in Europe and Central Asia, and the need for Legislative and Sentencing Reform, Eka Iakobishvili, Harm Reduction International, March 2012. http://www.ihra.net/files/2012/03/10/ihra_womeninprisonreport_web.pdf Data were collected from fifty-one European and Central Asian countries between August 2011 and February 2012, and obtained from government agencies, including national prison services, ministries of justice and drug agencies; as well as academic researchers and civil society organisations. Data providers were asked for the most recent, available numbers on national female prison populations both the total number and the number for drug offences, defined as: Crimes committed within the functioning of illicit drug markets, as part of the business of drug supply, distribution as well as drug law offences (crimes committed in violation of drug (and other related) legislation). This encapsulates a range of offences including possession, preparation, production, purchase, keeping, shipment, transfer or sale, illegal import or export, international transit shipment, illicit growing or cultivating of illicit plants. But it excludes acquisitive crime to obtain money for drugs; and crimes other than drug law offences committed under the influence. 3

(2) The European and Central Asian Female Prison Population for Drug Offences Country of women in prisons of women in prison for drug offences % of female prisoners serving sentences for drugs Female population in the country Albania 73 9 12.3 1597981 Andorra 6 ~ ~ 40753 Armenia 196 28 14 1645985 Austria 165 18 11 4285367 Azerbaijan 347 103 30 4515456 Belarus 3000 210 7 5154164 Belgium 471 142 30.1 5432623 Bosnia and Herzegovina 52 7 13.4 1954241 Bulgaria 300 40 14 3896823 Croatia 177 42 23.7 2288572 Cyprus 45 4 8.8 446895 Czech Republic 1493 168 13.4 5280608 Denmark 136 18 14 2758756 Estonia 136 62 46 722266 Finland 216 35 17 2715370 France 2200 308 14 32030798 Georgia 1169 386 34 2256415 Germany 3318 511 16 41880940 Greece 526 230 43.7 5628221 Hungary 1253 62 4.9 5249210 Iceland 7 4 57.1 157449 Ireland 138 32 23.1 2254301 Italy 2913 1252 42.9 30744127 Kazakhstan 4237 1080 25.4 8189953 Kyrgyzstan 300 100 33.3 2777222 Latvia 278 191 68.7 1212656 Liechtenstein 0 ~ ~ 18254 Lithuania 421 88 20.9 1748624 Luxembourg 39 8 20.5 245017 Macedonia 52 ~ ~ 1022501 Malta 39 ~ ~ 205154 4

Monaco 4 ~ ~ 16891 Montenegro 30 7 23.3 317411 Netherlands 627 197 31.4 8368118 Norway 206 67 32.5 2419969 Poland 2604 82 3.1 19709069 Portugal 682 325 47.6 5522407 Republic of Moldova 303 15 4.9 1891895 Romania 1370 177 12.9 10932250 Russian Federation 59000 19628 33.1 75777199 San Marino 0 ~ ~ 15777 Serbia 300 ~ ~ 4976678 Slovakia 477 131 27.4 2783408 Slovenia 68 16 23.5 1033426 Spain 6461 2935 45.4 22763627 Sweden 289 119 41 4659255 Switzerland 347 35 9.9 3871429 Tajikistan 600 420 70 3519960 Turkey 4728 739 15.6 37236294 Ukraine 6108 610 10 24631770 United Kingdom 4668 759 16-18 31363239 440 6 TOTAL 112 575 31 400 27.8 774 5

(3) The European Union Female Prison Population for Drug Offences Country of women in prisons of women in prison for drug offences % of female prisoners serving sentences for drugs Female population in the country Austria 165 18 11 4285367 Belgium 471 142 30.1 5432623 Bulgaria 300 40 14 3896823 Cyprus 45 4 8.8 446895 Czech Republic 1493 168 13.4 5280608 Denmark 136 18 14 2758756 Estonia 136 62 46 722266 Finland 216 35 17 2715370 France 2200 308 14 32030798 Germany 3318 511 16 41880940 Greece 526 230 43.7 5628221 Hungary 1253 62 4.9 5249210 Ireland 138 32 23.1 2254301 Italy 2913 1252 42.9 30744127 Latvia 278 191 68.7 1212656 Lithuania 421 88 20.9 1748624 Luxembourg 39 8 20.5 245017 Malta 39 ~ ~ 205154 Netherlands 627 197 31.4 8368118 Poland 2604 82 3.1 19709069 Portugal 682 325 47.6 5522407 Romania 1370 177 12.9 10932250 Slovakia 477 131 27.4 2783408 Slovenia 68 16 23.5 1033426 Spain 6461 2935 45.4 22763627 Sweden 289 119 41 4659255 United Kingdom 4668 759 16-18 31363239 TOTAL 31 333 7 910 25.2 253 872 555 6

(4) Report on the progress of the World s Women 2011-2012: In Pursuit of Justice, UN Women, July 2011 Further information: In Vienna: Eka Iakobishvilli, Human Rights Analyst, Harm Reduction International Mob: +44 (0)7925 610 407 Email eka@ihra.net Damon Barrett, Deputy Director, Harm Reduction International Mob: +44 (0)7933 730 640 Email damon.barrett@ihra.net 7